The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Recent developments in esophageal adenocarcinoma
Open accessAbstract
Answer questions and earn CME/CNE Esophageal adenocarcinoma (EAC) is characterized by 6 striking features: increasing incidence, male predominance, lack of preventive measures, opportunities for early detection, demanding surgical therapy and care, and poor prognosis. Reasons for its rapidly increasing incidence include the rising prevalence of gastroesophageal reflux and obesity, combined with the decreasing prevalence of Helicobacter pylori infection. The strong male predominance remains unexplained, but hormonal influence might play an important role. Future prevention might include the treatment of reflux or obesity or chemoprevention with nonsteroidal antiinflammatory drugs or statins, but no evidence‐based preventive measures are currently available. Likely future developments include endoscopic screening of better defined high‐risk groups for EAC. Individuals with Barrett esophagus might benefit from surveillance, at least those with dysplasia, but screening and surveillance strategies need careful evaluation to be feasible and cost‐effective. The surgery for EAC is more extensive than virtually any other standard procedure, and postoperative survival, health‐related quality of life, and nutrition need to be improved (eg, by improved treatment, better decision‐making, and more individually tailored follow‐up). Promising clinical developments include increased survival after preoperative chemoradiotherapy, the potentially reduced impact on health‐related quality of life after minimally invasive surgery, and the new endoscopic therapies for dysplastic Barrett esophagus or early EAC. The overall survival rates are improving slightly, but poor prognosis remains a challenge. CA Cancer J Clin 2013;63:232–248 . © 2013 American Cancer Society .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Treatment for Barrett's oesophagus
Rees, J. R. E., Lao-Sirieix, P., Wong, A., & Fitzgerald, R. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004060.pub2 · Cited by 76
RetractedRETRACTED: Increased Risk of Stomach and Esophageal Malignancies in People With AIDS
Persson, E. C., Shiels, M. S., Dawsey, S. M., Bhatia, K. G., Anderson, L. A., & Engels, E. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.013 · Cited by 44
RetractedEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Surgeon Volume and Operative Mortality in the United States
Birkmeyer, J. D., Stukel, T. A., Siewers, A. E., Goodney, P. P., Wennberg, D. E., & Lucas, F. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa035205 · Cited by 3,106
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,020
Self-citationGlobal burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Biere, S. S., van Berge Henegouwen, M. I., Maas, K. W., Bonavina, L., Rosman, C., Garcia, J. R., Gisbertz, S. S., Klinkenbijl, J. H., Hollmann, M. W., de Lange, E. S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60516-9 · Cited by 1,710
Sjoquist, K. M., Burmeister, B. H., Smithers, B. M., Zalcberg, J. R., Simes, R. J., Barbour, A., & Gebski, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70142-5 · Cited by 1,647
Variation in Hospital Mortality Associated with Inpatient Surgery
Ghaferi, A. A., Birkmeyer, J. D., & Dimick, J. B. (2009) · New England Journal of Medicine · doi:10.1056/nejmsa0903048 · Cited by 1,465
Cited by
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Lagergren, J., Smyth, E., Cunningham, D., & Lagergren, P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31462-9 · Cited by 1,141
Self-citationEpidemiology of esophageal cancer
Zhang, Y. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i34.5598 · Cited by 984
Kamangar, F., Nasrollahzadeh, D., Safiri, S., Sepanlou, S. G., Fitzmaurice, C., Ikuta, K. S., Bisignano, C., Islami, F., Roshandel, G., Lim, S. S., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30007-8 · Cited by 641
The Epidemiology of Esophageal Adenocarcinoma
Coleman, H. G., Xie, S.-H., & Lagergren, J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.07.046 · Cited by 549
Self-citation
Metadata
- Authors
- Lagergren, J., & Lagergren, P.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2013-07
- Volume
- 63
- Issue
- 4
- Pages
- 232-248
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W1530586963
- Cited by
- 309
- References
- 146
- FWCI
- 27.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent developments in esophageal adenocarcinoma. https://app.cochat.ai/papers/10.3322/caac.21185
- The paper
- Lagergren, J., & Lagergren, P. (2013). Recent developments in esophageal adenocarcinoma. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/caac.21185
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.